SCHEMBL17127351

SCHEMBL17127351

CCCCCSC(C(=O)c1ccc(Oc2ccc(OC)cc2)c2ccccc12)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 9/20 0.40
▸ CNR1 P21554 4/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ OPRK1 P41145 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ THRA P10827 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ CYSLTR2 Q9NS75 1/20 0.36
▸ CYSLTR1 Q9Y271 1/20 0.36
▸ HPGDS O60760 1/20 0.36
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ CDC25B P30305 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127328 0.80 CDC25B (0.37) CNR2CNR1MEN1KMT2ACDC25B
SCHEMBL17126858 0.80 CNR1 (0.41) CNR2CNR1CYP2C9THRATHRB
SCHEMBL17127352 0.80 FFAR1 (0.39) CNR2CNR1CYP2C9MEN1KMT2A
SCHEMBL17127027 0.80 PARP10 (0.44) MEN1KMT2ACYSLTR2CYSLTR1HTT
SCHEMBL17126857 0.78 APP (0.36) MEN1KMT2AHPGDSCDC25BNPSR1
SCHEMBL17126861 0.77 CNR1 (0.39) CNR2CNR1CYP2C9CDC25B
SCHEMBL17126974 0.76 PARP10 (0.46) MEN1KMT2AHTTLMNA
SCHEMBL17127336 0.75 HDAC3 (0.46) —
SCHEMBL17127330 0.75 CNR1 (0.41) CNR2CNR1CYP2C9CYSLTR2CYSLTR1
SCHEMBL17127331 0.74 CNR2 (0.42) CNR2CNR1CYP2C9THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS CNR2 4651/4885CNR1 4336/4885CYP2C9 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback